RecruitingPhase 2NCT06039631

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Studying Squamous cell carcinoma of the larynx

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fudan University
Intervention
Surgery(procedure)
Enrollment
82 target
Eligibility
18-75 years · All sexes
Timeline
2023 – 2029

Study locations (1)

Collaborators

Fudan University Eye Ear Nose and Throat Hospital · Shanghai Zhongshan Hospital · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Ruijin Hospital · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06039631 on ClinicalTrials.gov

Other trials for Squamous cell carcinoma of the larynx

Additional recruiting or active studies for the same condition.

See all trials for Squamous cell carcinoma of the larynx →

← Back to all trials